The emergence of Cognitive Computing for Cancer has revolutionized the healthcare industry. This technique is allowing a previously unattainable level of personalized treatment options with efficiency and simplicity. Due to this ability, it is anticipated that the Global Cancer Cognitive Computing market will cross US$ 4 Billion by 2022. The growth of the market is likely to be driven by advancements in computing platforms, rising installation of cognitive computing software in hospitals, increasing large and complex genomic datasets, and growing cancer incidences.
The report, “Global Cancer Cognitive Computing Market Outlook 2022”, provides an insight of the current and future prospective of this market. This report covers the major opportunities in this area, and the factors impacting the market growth. Furthermore, the report also provides insight regarding the trends persisting in the market.
Global as well as regional prevalence of cancer is also discussed in the report. This will help the reader to understand the potential of each region for cognitive computing for cancer. Moreover, the report also estimates the number of cancer specialty hospital in each region, with name of major hospitals. These hospitals could be the target for the incorporation of cancer cognitive computing solutions.
The report contains the Cancer Cognitive Computing market share of major regions, including North America, Europe, Asia-Pacific, and the Rest of the World. North America holds the largest market share, while Asia-Pacific is expected to witness highest growth in the coming years, i.e. 2016-2022. The major reasons for the high growth in Asia-Pacific are the ongoing researches in China and Japan, which is expanding cognitive computing applications to oncology. North America and Europe are expected to grow at a modest rate due to launch of new and innovative products in this market.
The last segment of the report is entirely devoted to profiling leading companies of the Cancer Cognitive Computing industry, including some major players like IBM, Microsoft, Google, Apple, Palantir, Palantir, Alacris, Enterra Solutions, GE Healthcare, etc. This segment provides access to the financials, product, services or technology portfolio, and recent developments of these companies. This segment also discusses the strengths and weaknesses of key players in this industry. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global Cancer Cognitive Computing market.